Antibody patterns can signal whether a person will develop inflammatory bowel disease (IBD) up to 10 years before diagnosis.

GLP-1 medications may reduce complications after surgery, with new research linking their use to fewer cardiovascular events ...

As one of the world’s most common genetic diseases, developing treatments for autosomal dominant polycystic kidney disease (ADPKD) is both a daunting and important task. Much research has been done to ...

Chinese researchers have identified a key molecular driver that could be targeted in an attempt to prevent osteoporosis. The findings, in Advanced Science, suggest interrupting this ...

The physical pressure that cancer cells encounter as tumors grow may do more than impede their movement. New research suggests that prolonged confinement can activate a molecular self-destruct ...

Children who develop cancer produce an unusually high number of antibodies that attack DNA repair machinery, new research suggests. The findings, published in Frontiers in Immunology, could help lead ...

A comprehensive review of earlier research studies suggests polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), is linked to brain changes associated ...

Differences in the bacteria living in the mouth and airways may be associated with the severity of long COVID.

At the 2026 Cell and Gene Meeting on the Mesa, biotech executives focused on value creation with differentiated technologies ...

A Phase III clinical trial found that nicotinamide riboside, an NAD-boosting supplement, did not slow Parkinson’s disease.

Simultaneously reprogramming immune cells and strengthening T cells can make glioblastoma tumors shrink and prevent ...

A study of nearly 40,000 patients suggests germline testing should be offered more broadly to adults diagnosed with solid ...